Company intelligence / Profile preview

Shenzhen Readline Biotech

Shenzhen, Guangdong, Chinalinkedin.com ↗

Ownership: Private
Development stage: Commercial

Overview

Shenzhen Readline Biotech is a synthetic biology-driven company specializing in the development and commercial production of green active ingredients—mainly peptides, proteins, sugars, and nucleic acids—for cosmetics, nutritional supplements, pharmaceuticals, animal health products, and agriculture. The company leverages a multidisciplinary technology platform to deliver sustainable solutions across health-related industries. No clinical trial results are reported as the business model focuses on ingredient supply rather than drug development.

Therapeutic areas: OtherDermatologyMetabolic Disorders
Modalities: PeptidesProteinsSugarsNucleic acids
Industry: Non-Drug Biotech

Partnerships

Integrity Ingredients Corp. for personal care ingredient distribution in North America

Beyond the preview

Go deeper on Shenzhen Readline Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shenzhen Readline Biotech.

Explore the full profile